As Congress considers lowering drug costs, pharma CEOs target key senators with campaign cash
TOM BRENNER/GETTY IMAGES
The execs are using their personal wealth to fund GOP lawmakers playing key roles in the Senate’s ongoing consideration of a bill to lower drug costs.
.png)
No hay comentarios:
Publicar un comentario